7.413
Mind Medicine Inc 주식(MNMD)의 최신 뉴스
Mind Medicine CEO Robert Barrow sells shares worth over $113k By Investing.com - Investing.com South Africa
Investing.com South Africa
Mind Medicine CEO Robert Barrow sells shares worth over $113k By Investing.com - Investing.com Australia
Investing.com Australia
Mind Medicine CEO Robert Barrow sells shares worth over $113k - Investing.com India
Investing.com India
MindMed's chief medical officer sells shares worth nearly $50k By Investing.com - Investing.com Canada
Investing.com Canada
Mind Medicine CEO Robert Barrow sells shares worth over $113k By Investing.com - Investing.com Canada
Investing.com Canada
Dan Karlin Sells 6,925 Shares of Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Stock - MarketBeat
MarketBeat
Mind Medicine CEO Robert Barrow sells shares worth over $113k By Investing.com - Investing.com
Investing.com
Brokerages Set Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Target Price at $20.00 - MarketBeat
MarketBeat
MindMed Advances GAD Treatment into Phase 3 Trials - TipRanks.com - TipRanks
TipRanks
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Defense World
Is Mind Medicine MindMed (MNMD) Outperforming Other Medical Stocks This Year? - MSN
MSN
Mind Medicine (MindMed) (NASDAQ:MNMD) Receives Overweight Rating from Cantor Fitzgerald - Defense World
Defense World
Intra-Cellular Therapies (NASDAQ:ITCI) Price Target Raised to $100.00 at Mizuho - Defense World
Defense World
Mind Medicine (MindMed) (NASDAQ:MNMD) Receives Overweight Rating from Cantor Fitzgerald - Defense World
Defense World
Mind Medicine (MindMed)'s (MNMD) "Overweight" Rating Reiterated at Cantor Fitzgerald - MarketBeat
MarketBeat
MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - StockTitan
StockTitan
MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference - Business Wire
Business Wire
MindMed advances LSD-based drug for GAD to Phase 3 trials - Investing.com India
Investing.com India
MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder ... - Business Wire
Business Wire
Is Mind Medicine MindMed (MNMD) Outperforming Other Medical Stocks This Year? - MSN
MSN
3 Top Canadian Psychedelic Stocks for June 2024 - Stocktrades.ca
Stocktrades.ca
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024 - InvestorPlace
InvestorPlace
Is Mind Medicine Inc (MNMD) a threat to investors? – US Post News - US Post News
US Post News
Mind Medicine Inc (MNMD) may enjoy gains as insiders got busy in the recent days – Knox Daily - Knox Daily
Knox Daily
(MNMD) Trading Signals - Stock Traders Daily
Stock Traders Daily
Is Mind Medicine MindMed (MNMD) Outperforming Other Medical Stocks This Year? - Yahoo Finance Australia
Yahoo Finance Australia
Is Mind Medicine MindMed (MNMD) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Yahoo Finance
Mind Medicine Inc [MNMD] Records 200-Day SMA of $5.50 – Knox Daily - Knox Daily
Knox Daily
7 Best Psychedelic Stocks in 2024 | Investing | U.S. News - U.S News & World Report Money
U.S News & World Report Money
7 Best Psychedelic Stocks in 2024 | Investing | U.S. News - U.S News & World Report Money
U.S News & World Report Money
7 Best Psychedelic Stocks in 2024 | Investing - U.S News & World Report Money
U.S News & World Report Money
7 Best Psychedelic Stocks in 2024 | Investing | U.S. News - U.S News & World Report Money
U.S News & World Report Money
Robert W. Baird analysts initates an Outperform rating for Mind Medicine Inc (MNMD) – Knox Daily - Knox Daily
Knox Daily
Mind Medicine (MindMed) (NASDAQ:MNMD) Trading Down 5.3% - MarketBeat
MarketBeat
A History of Outperforming Analyst Forecasts and Beating the Odds: Mind Medicine Inc (MNMD) – Sete News - SETE News
SETE News
Mind Medicine Inc: Navigating Market Fluctuations with a 221.62M Market Cap - The InvestChronicle
The InvestChronicle
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 7.3% - MarketBeat
MarketBeat
It would be worthwhile to take a closer look at Mind Medicine Inc (MNMD) – US Post News - US Post News
US Post News
MindMed to Participate in the Canaccord Genuity New Paradigms and Treatment Approaches in Mental Health ... - Marketscreener.com
Marketscreener.com
Why Earnings Season Could Be Great for Mind Medicine (MNMD) - Yahoo Movies UK
Yahoo Movies UK
Mind Medicine Inc [NASDAQ: MNMD] Sees Decrease in Stock Value – Knox Daily - Knox Daily
Knox Daily
Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) 18% loss last week hit both individual investors who own 46% as ... - Yahoo Finance
Yahoo Finance
Mind Medicine (MindMed) (OTCMKTS:MMEDF) Shares Down 2.8% - Defense World
Defense World
Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) 18% loss last week hit both individual investors who own 46% as ... - Yahoo Finance
Yahoo Finance
A better buy-in window may exist right now for Mind Medicine Inc (MNMD) – Sete News - SETE News
SETE News
Mind Medicine (MindMed) (NASDAQ:MNMD) Receives “Outperform” Rating from Royal Bank of Canada - Defense World
Defense World
Mind Medicine - Osler, Hoskin & Harcourt LLP
Osler, Hoskin & Harcourt LLP
Scotia Capital Inc. Takes $441000 Position in Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) - Defense World
Defense World
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Gap Down to $8.25 - MarketBeat
MarketBeat
MNMD’s Market Whiplash: 93.99% YTD Rise, -22.99% Plunge in 30 Days - The InvestChronicle
The InvestChronicle
자본화:
|
볼륨(24시간):